Alimera Sciences Appoints David Dyer, M.D. as Chief Retina Specialist
17 mai 2021 08h12 HE
|
Alimera Sciences, Inc.
ATLANTA, May 17, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced...